These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 5143279)

  • 1. [Insulin-like blood activity in patients with diabetes receiving antidiabetic sulfamides].
    Genes SG; Poltorak VV; Kozopolianskaia MM; Grinchenko TS; Lobanovskaia LI
    Vrach Delo; 1971 Nov; 11():57-60. PubMed ID: 5143279
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes of serum insulin during fasting and glucose loading before and after treatment of diabetes].
    Kosaka K; Hagura R; Ogawara H
    Dtsch Med J; 1970 Apr; 21(8):554-64. PubMed ID: 5510200
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma insulin studies in two hundred patients with diabetes mellitus.
    McKiddie MT; Buchanan KD; Hunter IA
    Q J Med; 1969 Oct; 38(152):445-65. PubMed ID: 5355537
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mechanism of the antidiabetic action of sulfanylurea derivatives].
    Iaroshevskiĭ IuA; Volkova EA
    Klin Med (Mosk); 1982 Oct; 60(10):94-7. PubMed ID: 6757562
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunoreactive insulin in the blood of patients with diabetes treated with insulin and diabetol].
    Smyk I
    Wiad Lek; 1980 Nov; 33(22):1803-8. PubMed ID: 7010794
    [No Abstract]   [Full Text] [Related]  

  • 6. [Repeated determination of fasting insulin like activity (IlA) in various groups of diabetics treated with insulin].
    Klein W; Dietzmann HB
    Dtsch Med J; 1967 Nov; 18(22):672-6. PubMed ID: 5600199
    [No Abstract]   [Full Text] [Related]  

  • 7. [Delayed action of oral antidiabetic treatments. Place of combination of insulin and hypoglycemic sulfamides].
    Leutenegger M; Nakib Y; Grulet H; Gross A; Boirie Y
    Journ Annu Diabetol Hotel Dieu; 1993; ():97-114. PubMed ID: 8331877
    [No Abstract]   [Full Text] [Related]  

  • 8. [Oral drug therapy of diabetes mellitus from the standpoint of blood insulin values].
    Murakami M; Takeda R; Miyabo S; Morimoto S; Fujimura A
    Saishin Igaku; 1967 Oct; 22(10):2311-9. PubMed ID: 5588196
    [No Abstract]   [Full Text] [Related]  

  • 9. [Oral treatment of diabetes mellitus with the new sulfonylurea tolazamide].
    Vogel G; Krummel E
    Arzneimittelforschung; 1969 Jul; 19(7):1128-30. PubMed ID: 5394514
    [No Abstract]   [Full Text] [Related]  

  • 10. Glibenclamide in the management of diabetes mellitus. I.
    Devlin JG; Manning K; Harty J
    J Ir Med Assoc; 1971 Apr; 64(409):197-9. PubMed ID: 5554337
    [No Abstract]   [Full Text] [Related]  

  • 11. [Initial treatment and prognosis of diabetes mellitus].
    Lohmann D; Kunze U; Schüritz P; Steltz G
    Dtsch Gesundheitsw; 1969 Feb; 24(7):296-301. PubMed ID: 5386441
    [No Abstract]   [Full Text] [Related]  

  • 12. [Oral antidiabetic monotherapy and combination treatment with glybenclamide (HB 419) and biguanides of insulin receiving diabetics of the adult type].
    Knick B; Wendt O; Konder ML; Netter P
    Med Klin; 1970 Jan; 65(3):109-12. PubMed ID: 5519048
    [No Abstract]   [Full Text] [Related]  

  • 13. [Dynamics of monosaccharides in the blood of patients with diabetes mellitus under the influence of treatment with hypoglycemic preparations].
    Masik MG; Franchuk MM
    Klin Med (Mosk); 1976 Mar; 54(3):116-9. PubMed ID: 966644
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hypoglycemic accidents in the therapeutic use of antidiabetic sulfamides (S.A.D.)].
    Argemi B; Melchior G; Lam-My S; Simonin R
    Mars Med; 1969; 106(10):783-9. PubMed ID: 5391194
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diabetes equilibration and evolution of weight curves in obese diabetic patients of type 1, during treatment with glucidoral].
    Joubaud F
    Therapeutique; 1971 May; 47(5):465-8. PubMed ID: 5562481
    [No Abstract]   [Full Text] [Related]  

  • 16. [Basal blood level of adrenocorticotropic hormone in diabetes mellitus patients].
    Bakov L; Milanov S
    Vutr Boles; 1984; 23(1):69-74. PubMed ID: 6328772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [N-acetyl-beta-D-glucosaminidase in the lymphocytes of patients with diabetes mellitus in relation to pharmacological treatment].
    Lisiewicz J; Moszczyński P
    Patol Pol; 1983; 34(3):291-300. PubMed ID: 6371689
    [No Abstract]   [Full Text] [Related]  

  • 18. Trial of a new antidiabetic compound (glycodiazine) in diabetes mellitus.
    Chugh RN; Bahl AL; Bhalla AS; Mathur KP
    J Indian Med Assoc; 1970 Jan; 54(2):62-5. PubMed ID: 5418147
    [No Abstract]   [Full Text] [Related]  

  • 19. [Thrombocyte aggregation in patients with diabetes mellitus before and after treatment with prodectin].
    Spesivtseva VG; Mamaeva GG; Kukes VG; Kasabian IN
    Sov Med; 1977 Jun; (6):65-70. PubMed ID: 897783
    [No Abstract]   [Full Text] [Related]  

  • 20. [Influence of therapy and adjustment of diabetics with xanthine nicotinate].
    Hahn J; Kaffarnik H
    Med Klin; 1969 May; 64(22):1042-5. PubMed ID: 5800195
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.